peys606
Gene therapyexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Apr 4, 2017 (NCT03308045)
Timeline
Indications
Studied for
Mechanism of action
- TNF-alphaINHIBITOR
TNF inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04207983 | Phase 2 | Jan 31, 2020 | EYEVENSYS S.A.S. |
| NCT03308045 | Phase 1/Phase 2 (Phase 2) | Apr 4, 2017 | EYEVENSYS S.A.S., Institut Cochin |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| EYEVENSYS S.A.S. | For profit | 2 | 2 | 1 | 2017 |
| Institut Cochin | Academic/Hospital | 1 | 0 | 1 | 2017 |
2 organizations
Page 1 / 1